Clinical Trials
2 trialsNCT02155920 2024-05-08
Everolimus for Children With Recurrent or Progressive Ependymoma
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT03387020 2021-08-27
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Pediatric Brain Tumor Consortium
Phase 1 Completed